MBL77 - AN OVERVIEW

Furthermore, lots of well set up adverse prognostic markers, which includes U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, lost their unfavorable effect in patients treated with VO. The only issue that remained predictive of the shorter development-no cost survival in this cohort of patients was TP53 aberrations.112 Eventually, the choice BTK in